Osteoarthritis Clinical Trial
Official title:
A Randomized Study of Single Shot vs 24hr vs 48hr Continuous Adductor Canal Block for Postoperative Analgesia After Total Knee Arthroplasty
The purpose of this study is to compare a single shot block, 24 hours, and 48 hour continuous catheter nerve block done via the adductor canal method in adult patients who have under gone total knee arthroplasty. Visual analogue scores, opioid consumption, time to up and go, ambulation, manual muscle tests, and Tinetti scores up to 72 hours post operatively will be used for comparison.
If the patient is willing to participate and signs the consent, he/she will be randomized to
one of the three treatment groups:
1. Single shot block
2. 24 hour catheter
3. 48 hour catheter
The choice of anesthetic technique will be at the discretion of the anesthesiologist. In our
institution we usually advocate for spinal anesthesia for total knee arthroplasty. All
patients will receive their multimodal perioperative pain protocol (MP3) medication as per
protocol in the patient receiving area (400 mg of gabapentin, 200 mg of Celecoxib, and 1gm of
acetaminophen).
Patients will be monitored during block performance with standard ASA monitors. All patients
will be receiving 2 L of oxygen via a nasal cannula. Sedatives will be titrated to effect.
Midazolam 1-2 mg, and fentanyl 50-100 mcg will be used for sedation.
Block time out will be preformed according to standard operating procedure. All blocks will
be done under ultrasound guidance. Sonosite S nerve machine will be used with a high
frequency linear (HFL) US probe with 6-13 MHZ frequency. Both single shot and continuous
adductor canal block will be performed according to the standard operating practices in our
department 4. Ultrasound survey at the medial part of the thigh will take place, halfway
between the superior anterior iliac spine and the patella. In a short axis view, the femoral
artery will be identified underneath the sartorius muscle, with the vein just inferior and
the saphenous nerve just lateral to the artery. The needle will be introduced in-plane and 2
to 3 mL of local anesthesia bolus will be used to verify correct placement of the needle in
the vicinity of the saphenous nerve in the adductor canal.
For single shot blocks: A bolus of total volume of 20 ml of ropivicaine 0.5% will be injected
through the needle.
For the continuous block: The catheter will be introduced and advanced 2-3 cm beyond the tip
of the needle under ultrasound visualization. The needle was withdrawn over the catheter.
Injection of a bolus of 5 ml of ropivacaine 0.5% will take place through the catheter while
observing the spread of local anesthetic under ultrasound. The catheter hub will be affixed
to the upper lateral thigh with sterile occlusive dressings and an anchoring device.
Block success will be defined as a change in cutaneous sensation to touch with an alcohol pad
in the saphenous nerve distribution over the medial leg within 30min after injection.
Subjects with successful catheter placement per protocol and nerve block onset were retained
in the study. Subjects with a failed catheter insertion or misplaced catheter indicated by a
lack of sensory changes had their catheter replaced or were withdrawn from the study.
At the conclusion of surgery, the catheters will be connected to a pump that will infuse
local anesthetic. Ropivicaine 0.2% at 8 ml/hour. In the postoperative anesthesia care unit,
intermittent boluses of hydromorphone will be used as needed. Postoperative analgesia will
follow the MP3 protocol. Drugs that are used for the multimodal analgesia protocol include
acetaminophen (1 gm every 8 hours for 72 hours), celecoxib (200 mg every 8 hours for 72
hours), Gabapentin (300 mg every 8 hours for one week if the patient is opioid naïve and for
two weeks if patients are opioid tolerant), and oxycodone (5-10-15 mg oral as needed every 4
hours for pain based on patient reported pain score).
All patients will receive prophylaxis for postoperative nausea and vomiting (PONV) during
surgery. The protocol for prophylaxis against PONV include administration of 4 mg of
dexamethasone after induction of anesthesia and 4 mg of ondansetron 20 minutes before
recovery from anesthesia. Dexamethasone is withheld if the patient has poorly controlled
diabetes mellitus (DM). Uncontrolled DM will be defined as random blood glucose above 250
mg/dl.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04657926 -
A Trial of APPA in the Treatment of Knee Osteoarthritis
|
Phase 2 | |
Completed |
NCT02536833 -
A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
|
Phase 2 | |
Completed |
NCT03014037 -
Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration
|
N/A | |
Recruiting |
NCT05937542 -
A Qualitative Investigation of CLEAT Participants
|
||
Completed |
NCT03644615 -
A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT06061367 -
Muscles Strength and Gait Parameteres After TKA
|
||
Withdrawn |
NCT04976972 -
A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03850665 -
Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach
|
N/A | |
Completed |
NCT02826902 -
Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial
|
N/A | |
Completed |
NCT04402502 -
Dynamic 4DCT to Examine Wrist Carpal Mechanics
|
N/A | |
Completed |
NCT02923700 -
Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial
|
Phase 4 | |
Completed |
NCT04564053 -
Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants
|
Phase 1 | |
Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
Not yet recruiting |
NCT05036174 -
Diphenhydramine Ointment for Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT02912429 -
Onlay vs. Inlay Patellofemoral Arthroplasty
|
N/A | |
Recruiting |
NCT02666443 -
Low Dose Dexamethasone in Supraclavicular Blocks
|
N/A | |
Active, not recruiting |
NCT02723929 -
Effects of tDCS and tUS on Pain Perception in OA of the Knee
|
||
Terminated |
NCT02820766 -
Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting
|
N/A | |
Withdrawn |
NCT02921594 -
Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties
|
N/A |